Issue Date: December 19, 2011
PCI Expands With Biogen Idec Pact
Spurred by a new collaboration with Biogen Idec, the contract manufacturer PCI Synthesis has expanded its R&D and kilolab facility in Devens, Mass. The 30% capacity boost will be supported by 20 new staff members in several functional areas. PCI says it has started working with Biogen Idec’s process research group to augment the drug company’s internal small-molecule production capabilities and optimize several new compounds.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society